Increased CXCR3+ T Cells Impairs Recruitment of T-Helper Type 17 Cells via Interferon γ and Interleukin 18 in the Small Intestine Mucosa During Treated HIV-1 Infection.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
31 07 2019
Historique:
received: 16 07 2018
accepted: 14 03 2019
pubmed: 19 3 2019
medline: 22 5 2020
entrez: 19 3 2019
Statut: ppublish

Résumé

The restoration of CD4+ T cells, especially T-helper type 17 (Th17) cells, remains incomplete in the gut mucosa of most human immunodeficiency virus type 1 (HIV-1)-infected individuals despite sustained antiretroviral therapy (ART). Herein, we report an increase in the absolute number of CXCR3+ T cells in the duodenal mucosa during ART. The frequencies of Th1 and CXCR3+ CD8+ T cells were increased and negatively correlated with CCL20 and CCL25 expression in the mucosa. In ex vivo analyses, we showed that interferon γ, the main cytokine produced by Th1 and effector CD8+ T cells, downregulates the expression of CCL20 and CCL25 by small intestine enterocytes, while it increases the expression of CXCL9/10/11, the ligands of CXCR3. Interleukin 18, a pro-Th1 cytokine produced by enterocytes, also contributes to the downregulation of CCL20 expression and increases interferon γ production by Th1 cells. This could perpetuate an amplification loop for CXCR3-driven Th1 and effector CD8+ T cells recruitment to the gut, while impairing Th17 cells homing through the CCR6-CCL20 axis in treated HIV-1-infected individuals.

Identifiants

pubmed: 30880342
pii: 5382280
doi: 10.1093/infdis/jiz123
doi:

Substances chimiques

Anti-Retroviral Agents 0
CCL20 protein, human 0
CCL25 protein, human 0
CXCL10 protein, human 0
CXCL11 protein, human 0
CXCL9 protein, human 0
CXCR3 protein, human 0
Chemokine CCL20 0
Chemokine CXCL10 0
Chemokine CXCL11 0
Chemokine CXCL9 0
Chemokines, CC 0
Cytokines 0
IL18 protein, human 0
Interleukin-18 0
Receptors, CXCR3 0
Interferon-gamma 82115-62-6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

830-840

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

C Loiseau (C)

INSERM, UMR1043, Toulouse, France.
aPresent affiliation: Centre for Molecular Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Australia.

M Requena (M)

Laboratoire de Virologie, Toulouse, France.

M Nayrac (M)

INSERM, UMR1043, Toulouse, France.

M Mavigner (M)

Department of Pediatrics, Atlanta, Georgia.
Center for AIDS Research, Emory University School of Medicine, Atlanta, Georgia.

M Cazabat (M)

Laboratoire de Virologie, Toulouse, France.

A L Iscache (AL)

INSERM, UMR1043, Toulouse, France.

N Carrere (N)

Service de Chirurgie générale et digestive, Toulouse, France.
Université Toulouse III Paul Sabatier, Toulouse, France.

B Suc (B)

Service de Chirurgie générale et digestive, Toulouse, France.
Université Toulouse III Paul Sabatier, Toulouse, France.

L Alric (L)

Service de Médecine Interne, Toulouse, France.
Université Toulouse III Paul Sabatier, Toulouse, France.
IRD UMR152, Toulouse, France.

J Izopet (J)

INSERM, UMR1043, Toulouse, France.
Laboratoire de Virologie, Toulouse, France.
Université Toulouse III Paul Sabatier, Toulouse, France.

P Delobel (P)

INSERM, UMR1043, Toulouse, France.
Service des Maladies Infectieuses et Tropicales, CHU de Toulouse, Toulouse, France.
Université Toulouse III Paul Sabatier, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH